<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">bmjour</journal-id><journal-title-group><journal-title xml:lang="ru">Байкальский медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Baikal Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2949-0715</issn><publisher><publisher-name>Irkutsk State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.57256/2949-0715-2023-2-37-44</article-id><article-id custom-type="elpub" pub-id-type="custom">bmjour-7</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Оригинальные статьи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Original articles</subject></subj-group></article-categories><title-group><article-title>ЭТИОЛОГИЧЕСКАЯ ХАРАКТЕРИСТИКА ХРОНИЧЕСКИХ ВИРУСНЫХ ГЕПАТИТОВ В ХОРЕЗМСКОЙ ОБЛАСТИ УЗБЕКИСТАНА</article-title><trans-title-group xml:lang="en"><trans-title>ETIOLOGICAL CHARACTERISTICS OF CHRONIC VIRAL HEPATITIS IN THE KHOREZM REGION OF UZBEKISTAN</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0000-7106-8780</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Юсупов</surname><given-names>Шавкат Рахимбаевич</given-names></name><name name-style="western" xml:lang="en"><surname>Yusupov</surname><given-names>Shavkat R.</given-names></name></name-alternatives><email xlink:type="simple">yushr2017@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8612-0948</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аитов</surname><given-names>Курбан Аитович</given-names></name><name name-style="western" xml:lang="en"><surname>Aitov</surname><given-names>Kurban A.</given-names></name></name-alternatives><email xlink:type="simple">yushr2017@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9217-6876</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Савилов</surname><given-names>Евгений Дмитриевич</given-names></name><name name-style="western" xml:lang="en"><surname>Savilov</surname><given-names>Evgeny D.</given-names></name></name-alternatives><email xlink:type="simple">savilov47@gmail.com</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0006-1002-6409</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Абдуллаева</surname><given-names>Дилфуза Кадамовна</given-names></name><name name-style="western" xml:lang="en"><surname>Abdullayeva</surname><given-names>Dilfuza K.</given-names></name></name-alternatives><email xlink:type="simple">dilfuza_abdullayeva_infec@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0005-9984-5111</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Умиров</surname><given-names>Сафар Эргашевич</given-names></name><name name-style="western" xml:lang="en"><surname>Umirov</surname><given-names>Safar E.</given-names></name></name-alternatives><email xlink:type="simple">tta.umirov@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Ургенчский филиал Ташкентской медицинской академии минздрава Республики Узбекистан</institution><country>Узбекистан</country></aff><aff xml:lang="en"><institution>Tashkent Medical Academy, Urgench branch</institution><country>Uzbekistan</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО Иркутский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Irkutsk State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБНУ «Научный центр проблем здоровья семьи и репродукции человека»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Research Center for Family Health and Human Reproduction</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>10</day><month>06</month><year>2023</year></pub-date><volume>2</volume><issue>2</issue><fpage>37</fpage><lpage>44</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Юсупов Ш.Р., Аитов К.А., Савилов Е.Д., Абдуллаева Д.К., Умиров С.Э., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Юсупов Ш.Р., Аитов К.А., Савилов Е.Д., Абдуллаева Д.К., Умиров С.Э.</copyright-holder><copyright-holder xml:lang="en">Yusupov S.R., Aitov K.A., Savilov E.D., Abdullayeva D.K., Umirov S.E.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.bmjour.ru/jour/article/view/7">https://www.bmjour.ru/jour/article/view/7</self-uri><abstract><p>Представлено исследование этиологической структуры хронических вирусных гепатитов с учетом оценки стадии патологического процесса и генотипической принадлежности возбудителей на территории Хорезмской области Республики Узбекистан. Показано, что в Хорезмской области Узбекистана в этиологической структуре хронических вирусных гепатитов представлены в виде моноинфекции в 42,3% случаев, в 70,7% случаев в ассоциации с другими формами., в том числе хронический гепатит С в виде моноинфекции составляет 29,3%, а в ассоциации с другими формами 42,4%. Частота хронического гепатита D составляет 15,3%. Явления фиброза отмечаются у 95,8% больных хроническим вирусным гепатитом и усугубляются при ассоциировании различных форм хронических вирусных гепатитов. Доминирующим генотипом является генотип 1b вирусного гепатита С. Частота выявления этого генотипа нарастает с прогрессированием стадии заболевания. У пациентов с хроническим вирусным гепатитом D все амплифицированные изоляты принадлежали к генотипу HBV, а изоляты HDV к генотипу 1.</p><p>Заключение. При лечении и диагностики хронических вирусных гепатитов следует учесть их этиологическую картину. Это позволит более эффективно решать проблемы реализации Стратегии Всемирной организации здравоохранения и Правительства Республики Узбекистан в отношении хронических вирусных гепатитов.</p></abstract><trans-abstract xml:lang="en"><p>A study of the etiological structure of chronic viral hepatitis is presented, taking into account the assessment of the stage of the pathological process and the genotypic affiliation of pathogens in the Khorezm region of the Republic of Uzbekistan. It is shown that in the Khorezm region of Uzbekistan in the etiological structure of chronic viral hepatitis are presented as monoinfection in 42.3% of cases, in 70.7% of cases in association with other forms, including chronic hepatitis C in the form of monoinfection is 29.3 %, and in association with other forms 42.4%. The frequency of chronic hepatitis D is 15.3%. The phenomena of fibrosis are observed in 95.8% of patients with chronic viral hepatitis and are aggravated by the association of various forms of chronic viral hepatitis. The dominant genotype is genotype 1b of viral hepatitis C. The frequency of detection of this genotype increases with the progression of the stage of the disease. In patients with chronic viral hepatitis D, all amplified isolates belonged to the HBV genotype, and HDV isolates to genotype 1.</p><p>Conclusion. When treating and diagnosing chronic viral hepatitis, their etiological picture should be taken into account. This will more effectively solve the problems of implementing the Strategy of the World Health Organization and the Government of the Republic of Uzbekistan in relation to chronic viral hepatitis.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>хронические вирусные гепатиты</kwd><kwd>этиологическая структура</kwd><kwd>степени фиброза</kwd><kwd>генотипы вирусов гепатитов В</kwd><kwd>С и D</kwd></kwd-group><kwd-group xml:lang="en"><kwd>chronic viral hepatitis</kwd><kwd>etiological structure</kwd><kwd>degrees of fibrosis</kwd><kwd>genotypes of hepatitis B</kwd><kwd>C and D viruses</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Камилов Ф.Х. и др. Частота встречаемости различных этиологических форм хронических вирусных гепатитов и циррозов печени. Инфекция, иммунитет и фармакология. 2010;(1-2):102-105 [Kamilov F.Kh. et al. Frequency of occurrence of various etiological forms of chronic viral hepatitis and cirrhosis of the liver. Infection, immunity and pharmacology. 2010;(1-2):102-105 (In Russian)].</mixed-citation><mixed-citation xml:lang="en">Kamilov F.Kh. et al. Frequency of occurrence of various etiological forms of chronic viral hepatitis and cirrhosis of the liver. Infection, immunity and pharmacology. 2010;(1-2):102-105 (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ахмедова М.Д., Ташпулатова Ш.А., Ихтиярова Г.А., Каримова М.Т. Хронические вирусные гепатиты B и D у беременных: распространенность, течение и исходы (обзор литературы). Журнал инфектологии. 2021;13(2):29-37 [Akhmedova M.D., Tashpulatova S.A., Ikhtiyarova G.A., Karimova M.T. Chronic viral hepatitis B and D in pregnant women: course and outcomes (review). Journal Infectology. 2021;13(2):29-37. (In Russian)]. https://doi.org/10.22625/2072-6732-2021-13-2-29-37</mixed-citation><mixed-citation xml:lang="en">Akhmedova M.D., Tashpulatova S.A., Ikhtiyarova G.A., Karimova M.T. Chronic viral hepatitis B and D in pregnant women: course and outcomes (review). Journal Infectology. 2021;13(2):29-37 (In Russian). https://doi.org/10.22625/2072-6732-2021-13-2-29-37</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ахмедова А.Х., Иноятова Ф.И., Валиева Н.К. Маркерный профиль HBV-инфекции у детей, больных хроническим гепатитом В, с задержкой полового развития. Сборник материалов XII Всероссийской научно-практической конференции с международным участием «Вирусные гепатиты - достижения и новые перспективы». М.;2019:11-13 [Akhmedova A.Kh., Inoyatova F.I., Valieva N.K. Marker profile of HBV infection in children with chronic hepatitis B with delayed puberty. Collection of materials of the XII All-Russian scientific and practical conference with international participation "Viral hepatitis - achievements and new prospects". M.;2019:11-13 (In Russian)].</mixed-citation><mixed-citation xml:lang="en">Akhmedova A.Kh., Inoyatova F.I., Valieva N.K. Marker profile of HBV infection in children with chronic hepatitis B with delayed puberty. Collection of materials of the XII All-Russian scientific and practical conference with international participation "Viral hepatitis - achievements and new prospects". M.;2019:11-13 (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Шахгильдян И.В., Михайлов М.И., Онищенко Г.Г. Парентеральные вирусные гепатиты (эпидемиология, диагностика, профилактика). М.;2003:384 [Shakhgildyan I.V., Mikhailov M.I., Onishchenko G.G. Parenteral viral hepatitis (epidemiology, diagnosis, prevention). M.;2003:384 (In Russian)].</mixed-citation><mixed-citation xml:lang="en">Shakhgildyan I.V., Mikhailov M.I., Onishchenko G.G. Parenteral viral hepatitis (epidemiology, diagnosis, prevention). M.;2003:384 (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Савилов Е.Д., Малов С.И., Малов И.В. и др. Эпидемиологические проявления вирусного гепатита С у представителей европеоидной и монголоидной рас. Журнал микробиологии, эпидемиологии и иммунобиологии. 2016;(1):9-16 [Savilov E. D., Malov S. I., Malov I. V. et al. Epidemiologic manifestations of viral hepatitis c in representatives of caucasian and mongoloid races. Journal of microbiology, epidemiology and immunobiology. 2016;(1):9-16 (In Russian)]. https://doi.org/10.36233/0372-9311-2016-1-9-17</mixed-citation><mixed-citation xml:lang="en">Savilov E. D., Malov S. I., Malov I. V. et al. Epidemiologic manifestations of viral hepatitis c in representatives of caucasian and mongoloid races. Journal of microbiology, epidemiology and immunobiology. 2016;(1):9-16 (In Russian). https://doi.org/10.36233/0372-9311-2016-1-9-17</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Малов С.И., Малов И.В., Дворниченко В.В. и др. Применение комбинации альфа-фетопротеина и остеопонтина для ранней диагностики гепатоцеллюлярной карциномы, ассоциированной с гепатитом С. Клиническая лабораторная диагностика. 2019;64(10):607-612 [Malov S.I. , Malov I.V., Dvornichenko V.V. et al. Application of alpha-fetoprotein and osteopontin combination for early diagnosis of hepatocellular carcinoma associated with hepatitis C. Klinicheskaya Laboratornaya Diagnostika (Russian Clinical Laboratory Diagnostics). 2019;64(10): 607-612 (In Russian)]. https://doi.org/10.18821/0869-2084-2019-64-10-607-612</mixed-citation><mixed-citation xml:lang="en">Malov S.I., Malov I.V., Dvornichenko V.V. et al. Application of alpha-fetoprotein and osteopontin combination for early diagnosis of hepatocellular carcinoma associated with hepatitis C. Klinicheskaya Laboratornaya Diagnostika (Russian Clinical Laboratory Diagnostics). 2019;64(10): 607-612 (In Russian). https://doi.org/10.18821/0869-2084-2019-64-10-607-612</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Menner A.S., Kinkel H.T., Dixit S.M. et al. Prevalence and behavioural risk factors for hepatitis B in Upper Dolpo, Nepal. Journal of Public Health. 2019;20(3):481-488. https://doi.org/10.1007/s10389-019-01152-7</mixed-citation><mixed-citation xml:lang="en">Menner A.S., Kinkel H.T., Dixit S.M. et al. Prevalence and behavioural risk factors for hepatitis B in Upper Dolpo, Nepal. Journal of Public Health. 2019;20(3):481-488. https://doi.org/10.1007/s10389-019-01152-7</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Информационный бюллетень ВОЗ, июль 2019. Социальные аспекты здоровья населения. 2019;65(4) [WHO fact sheet, July 2019. Social aspects of population health. 2019;65(4) (In Russian)]. URL: http://vestnik.mednet.ru/content/view/1093/30/lang,ru/ [дата доступа: 27.02.2023].</mixed-citation><mixed-citation xml:lang="en">WHO fact sheet, July 2019. Social aspects of population health. 2019;65(4) (In Russian)]. URL: http://vestnik.mednet.ru/content/view/1093/30/lang,ru/ [accessed: 27.02.2023].</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Гепатит Д. Всемирная организация здравоохранения [Hepatitis D. World Health Organization]. URL: https://www.who.int/ru/news-room/fact-sheets/detail/hepatitis-d [дата доступа: 27.02.2023].</mixed-citation><mixed-citation xml:lang="en">Hepatitis D. World Health Organization. URL: https://www.who.int/ru/news-room/fact-sheets/detail/hepatitis-d [accessed: 27.02.2023].</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Голубовская О.А., Пронюк К.Е Достижения и проблемы на пути элиминации гепатита С в рамках Глобальной стратегии ВОЗ. Клиническая инфектология и паразитология. 2018;7(3):382-388 [Golubovskaya O., Pronyuk Kh. Achievements and challenges of elimination of hepatitis C in the framework of WHO Global Strategy. Clinical infectology and parasitology. 2018;7(3):382-388 (In Russian)].</mixed-citation><mixed-citation xml:lang="en">Golubovskaya O., Pronyuk Kh. Achievements and challenges of elimination of hepatitis C in the framework of WHO Global Strategy. Clinical infectology and parasitology. 2018;7(3):382-388 (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Вирусный гепатит. Доклад секретариата Всемирной организации здравоохранения. 134 сессия всемирной ассамблеи здравоохранения. Пункт 10.5 повестки дня. EB134.R18 от 25.01.2014 [Viral hepatitis. Report of the Secretariat of the World Health Organization. 134th World Health Assembly. Item 10.5 of the agenda. EB134.R18 from 01/25/2014]. URL: https://iris.who.int/items/c4d5e342-0ca9-419a-8571-49baef50370e [дата доступа: 27.02.2023]</mixed-citation><mixed-citation xml:lang="en">Viral hepatitis. Report of the Secretariat of the World Health Organization. 134th World Health Assembly. Item 10.5 of the agenda. EB134.R18 from 01/25/2014. URL: https://iris.who.int/items/c4d5e342-0ca9-419a-8571-49baef50370e [accessed: 27.02.2023]</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Жданов К.В., Лобзин Ю.В., Гусев Д.А., Козлов К.В. Вирусные гепатиты. СПб.: Фолиант;2011:304 [Zhdanov K.V., Lobzin Yu.V., Gusev D.A., Kozlov K.V. Viral hepatitis. St. Petersburg: Foliant; 2011:304 (In Russian)].</mixed-citation><mixed-citation xml:lang="en">Zhdanov K.V., Lobzin Yu.V., Gusev D.A., Kozlov K.V. Viral hepatitis. St. Petersburg: Foliant; 2011:304 (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Савилов Е.Д., Чемезова Н.Н., Астафьев В.А. и др. Парентеральные вирусные гепатиты в иркутской области. Acta Biomedica Scientifica. 2018;3(5):148-153 [Savilov E.D., Chemezova N.N., Astafev V.A. et al. Parenteral viral hepatitises in the irkutsk region. Acta Biomedica Scientifica. 2018;3(5):148-153 (In Russian)]. https://doi.org/10.29413/ABS.2018-3.5.22</mixed-citation><mixed-citation xml:lang="en">Savilov E.D., Chemezova N.N., Astafev V.A. et al. Parenteral viral hepatitises in the irkutsk region. Acta Biomedica Scientifica. 2018;3(5):148-153 (In Russian). https://doi.org/10.29413/ABS.2018-3.5.22</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Постановление Президента Республики Узбекистан (ПП РУз) от 16.05.2022 г. «О совершенствовании мер противодействия распространению некоторых актуальных вирусных инфекций» [Decree of the President of the Republic of Uzbekistan (RD of the Republic of Uzbekistan) dated May 16, 2022 «On improving measures to counteract the spread of certain topical viral infections»]. URL: https://president.uz/ru/lists/view/5203 [дата доступа: 27.02.2023]</mixed-citation><mixed-citation xml:lang="en">Decree of the President of the Republic of Uzbekistan (RD of the Republic of Uzbekistan) dated May 16, 2022 «On improving measures to counteract the spread of certain topical viral infections». URL: https://president.uz/ru/lists/view/5203 [accessed: 27.02.2023]</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
